STARBUCKS ($SBUX) is expected to release its quarterly earnings data on Monday, April 28th after market close, per Finnhub. Analysts are expecting revenue of $9,061,842,955 and earnings of $0.52 per share.
You can see Quiver Quantitative's $SBUX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
STARBUCKS Insider Trading Activity
STARBUCKS insiders have traded $SBUX stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $SBUX stock by insiders over the last 6 months:
- SARA KELLY (evp, chief partner officer) sold 19,102 shares for an estimated $1,936,369
- RACHEL RUGGERI (evp, cfo) has made 0 purchases and 2 sales selling 2,943 shares for an estimated $292,263.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
STARBUCKS Hedge Fund Activity
We have seen 929 institutional investors add shares of STARBUCKS stock to their portfolio, and 1,257 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS added 9,174,682 shares (+20.1%) to their portfolio in Q4 2024, for an estimated $837,189,732
- FMR LLC added 5,348,790 shares (+27.0%) to their portfolio in Q4 2024, for an estimated $488,077,087
- CITADEL ADVISORS LLC added 4,761,388 shares (+3086.4%) to their portfolio in Q4 2024, for an estimated $434,476,655
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 4,485,660 shares (-92.8%) from their portfolio in Q4 2024, for an estimated $409,316,475
- BANK OF AMERICA CORP /DE/ removed 4,273,605 shares (-20.7%) from their portfolio in Q4 2024, for an estimated $389,966,456
- PRICE T ROWE ASSOCIATES INC /MD/ removed 3,935,784 shares (-21.7%) from their portfolio in Q4 2024, for an estimated $359,140,290
- MIZUHO SECURITIES USA LLC removed 3,892,570 shares (-97.3%) from their portfolio in Q4 2024, for an estimated $355,197,012
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
STARBUCKS Congressional Stock Trading
Members of Congress have traded $SBUX stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $SBUX stock by members of Congress over the last 6 months:
- REPRESENTATIVE SUSIE LEE sold up to $50,000 on 03/14.
- REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
- SENATOR SHELDON WHITEHOUSE has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 10/29.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
STARBUCKS Analyst Ratings
Wall Street analysts have issued reports on $SBUX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 01/29/2025
- Deutsche Bank issued a "Buy" rating on 01/29/2025
- Citigroup issued a "Buy" rating on 01/27/2025
- RBC Capital issued a "Outperform" rating on 01/27/2025
- CFRA issued a "Reduce" rating on 10/31/2024
- Barclays issued a "Overweight" rating on 10/31/2024
To track analyst ratings and price targets for STARBUCKS, check out Quiver Quantitative's $SBUX forecast page.
STARBUCKS Price Targets
Multiple analysts have issued price targets for $SBUX recently. We have seen 4 analysts offer price targets for $SBUX in the last 6 months, with a median target of $104.5.
Here are some recent targets:
- An analyst from Barclays set a target price of $106.0 on 04/22/2025
- Chris O'Cull from Stifel Nicolaus set a target price of $103.0 on 04/15/2025
- Logan Reich from RBC Capital set a target price of $115.0 on 11/15/2024
- Arun Sundaram from CFRA set a target price of $103.0 on 10/31/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.